Cabozantinib in Hepatocellular Carcinoma

  • Maeda, Osamu M.D., Ph.D.
  • Ando, Yuichi M.D., Ph.D.

Dr. Ando reports receiving research grants from Takeda Pharmaceutical. No other potential conflict of interest relevant to this letter was reported.

New England Journal of Medicine 379(14):p 1384, October 4, 2018. | DOI: 10.1056/NEJMc1810178
Copyright © 2018 Massachusetts Medical Society. All rights reserved.